SABRINA SERGENT: Open Payments
NPI 1891490074 · HARLAN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$425 in 24 payments from 10 companies in 2025. Trend: 2023 $110 · 2024 $273 · 2025 $425
Food & beverage: $425
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $90 |
| ABBVIE INC. | 5 | $81 |
| Vanda Pharmaceuticals Inc. | 4 | $74 |
| Otsuka America Pharmaceutical, Inc. | 3 | $43 |
| Supernus Pharmaceuticals, Inc. | 1 | $32 |
| Neurocrine BioSciences, Inc. | 2 | $32 |
| OWP Pharmaceuticals, Inc. | 1 | $23 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
| Axsome Therapeutics, Inc. | 1 | $16 |
| Alkermes, Inc. | 1 | $16 |
Products named: CAPLYTA, VRAYLAR, HETLIOZ, REXULTI, Qelbree, INGREZZA, Subvenite, FANAPT.
Industry payments across KY — which companies pay providers there.
